» Articles » PMID: 20175454

Activin, TGF-beta and Menin in Pituitary Tumorigenesis

Overview
Date 2010 Feb 24
PMID 20175454
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors. Prolactin-secreting pituitary adenomas (prolactinomas) are the most common form of pituitary tumors in humans. They are associated with excessive release of the hormone prolactin and increased tumor growth, giving rise to severe endocrine disorders and serious clinical concerns for the patients. Recent studies indicated that the activin/TGF-beta family of growth factors plays a prominent role in regulating pituitary tumor growth and prolactin secretion from anterior pituitary lactotrope cells. Furthermore, these studies highlighted the tumor suppressor menin and the protein Smads as central regulators of these biological processes in the pituitary. Alterations in the activin/TGF-beta downstream signaling pathways are critical steps towards tumor formation and progression. This chapter will review the role and intracellular molecular mechanisms of action by which activin, TGF-beta, Smads and menin act in concert to prevent pituitary tumor cell growth and control hormonal synthesis by the anterior pituitary.

Citing Articles

Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.

Boudreault J, Canaff L, Ghozlan M, Wang N, Guarnieri V, Salcuni A Cells. 2024; 13(11.

PMID: 38891107 PMC: 11172218. DOI: 10.3390/cells13110973.


Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues.

Saksis R, Rogoza O, Niedra H, Megnis K, Mandrika I, Balcere I Cancer Cell Int. 2023; 23(1):25.

PMID: 36774501 PMC: 9922463. DOI: 10.1186/s12935-023-02863-4.


SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma.

Huang R, Chen D, Wang H, Zhang B, Zhang Y, Ren W J Oncol. 2022; 2022:4272525.

PMID: 36276274 PMC: 9586780. DOI: 10.1155/2022/4272525.


Identification of Transcriptional Metabolic Dysregulation in Subtypes of Pituitary Adenoma by Integrated Bioinformatics Analysis.

Hu J, Yin H, Li B, Yang H Diabetes Metab Syndr Obes. 2019; 12:2441-2451.

PMID: 31819570 PMC: 6885545. DOI: 10.2147/DMSO.S226056.


Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas.

Darvasi O, Szabo P, Nemeth K, Szabo K, Spisak S, Liko I Pathol Oncol Res. 2017; 25(1):169-182.

PMID: 29043608 DOI: 10.1007/s12253-017-0330-3.